On February 23, United States Agency for International Development (USAID) Assistant Administrator for Global Health Dr. Atul Gawande announced that the U.S. government will surge resources to Nigeria through the Initiative for Global Vaccine Access (Global VAX). The U.S. government effort aims to increaseCOVID-19 vaccination rates.
Global VAX augments the U.S. government’s international vaccine support in Nigeria. The U.S. is the largest donor to COVAX and already has supplied over 21.7 million doses to Nigeria as well as technical and logistical support.
Dr. Gawande told the Abuja Ports to Arms Conference that, “the Nigerian government has shown its commitment to increasing the uptake of COVID-19 vaccines, and we are proud to partner with it as the United States launches this important initiative to boost global vaccination rates.” He added, “We are calling on other countries to engage further and contribute expertise and resources to identify and rapidly overcome vaccine access barriers experienced by communities around the world, especially in Africa.”
“We are pleased to have a close partnership with the Government of Nigeria on the COVID-19 response,” said U.S. Ambassador to Nigeria Mary Beth Leonard. “Given the progress Nigeria has made, and the potential to make significant, additional advancement, we are pleased to surge more resources to help rapidly increase vaccination rates.”
Since 2020, the United States has provided $143 million to support Nigeria’s COVID-19 response. As part of Global VAX, USAID plans to provide an additional $33.3 million in Nigeria to support activities that may include bolstering cold chain supply and logistics, addressing vaccine confidence and demand, and increasing the accessibility of vaccination sites. Global VAX also will support Nigeria’s existing vaccination plans, and will help get vaccines to people quickly, safely, and equitably.
This is part of an announcement made in December 2021, that the U.S. government would provide an additional $315 million for Global VAX, bringing the total U.S. government commitment to vaccine readiness and delivery to more than $1.7 billion.
Global VAX is a whole-of-U.S.-government effort to accelerate vaccine uptake toward the global goal to vaccinate 70 percent of the world population against COVID-19 in 2022.Distributed by APO Group on behalf of U.S. Embassy and Consulate in Nigeria.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.